Form 4 for ANGO ANGIODYNAMICS INC

Accepted 2021-10-06 00:00:00 ET · period of report 2021-10-05 · accession 0001567619-21-017999 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-10-06	2021-10-05	ANGO	Campbell Chad Thomas	SVP, GM, Vascular Access	S - Sale+OE	$27.15	-10.7K	31.7K	-25%	-$291.8K
D	2021-10-06	2021-10-05	ANGO	Campbell Chad Thomas	SVP, GM, Vascular Access	M - OptEx	$16.59	+10.7K	42.5K	+34%	+$178.3K
D	2021-10-06	2021-10-05	ANGO	Campbell Chad Thomas	SVP, GM, Vascular Access	M - OptEx	$0.00	-10.7K	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-10-05	S	D	10,748	$27.15	31,741	D	—	—	(F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.07 to $27.35, inclusive. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.
2	Common	Common Stock	2021-10-05	M	A	10,748	$16.59	42,489	D	—	—
3	Derivative	Non-Qualified Stock Option (right to buy)	2021-10-05	M	D	10,748	$0.00	0	D	$16.59 · 2020-07-27 to 2023-07-25	10,748 Common Stock	(F2) Options for one-fourth of the shares became exercisable on 7/27/2017, 7/27/2018, 7/27/2019 and 7/27/2020, respectively.